Founded in July 2006, Shandong Huaxipharm Co., LTD is a modern private pharmaceutical group co-invested by Beijing Huaxipharm Co., LTD, it covers 78,000 square meters with a total invest more than 120 million RMB, specializing in the development, production and marketing of generic and proprietary branded drugs as well as active pharmaceutical ingredients.
Huaxipharm Group specializing in developing new drug focuses on neuroscience, endocrine disorders, cancer, infectious diseases, cardiovascular diseases, and inflammation therapeutic area. Long-term extensive cooperation has been maintained with many international enterprises and more than 60 local companies